News
- Author:
- Patricia McKnight
Publish date: April 28, 2023
“Providing treating oncologists with a timely opportunity to alter therapy or providing patients with support, guidance, and earlier access to reha...
News
- Author:
- Patricia McKnight
Publish date: March 22, 2023
The therapy lutetium Lu 177 vipivotide tetraxetan will remain in limited supply until the drug’s manufacturer can ramp up production.
News
- Author:
- Patricia McKnight
Publish date: March 13, 2023
Use of the film significantly reduced the incidence of grade 2 or 3 radiation dermatitis in a study of women with breast cancer.
News
- Author:
- Patricia McKnight
Publish date: March 7, 2023
The new expansion removes the Ki-67 testing requirement.
News
- Author:
- Patricia McKnight
Publish date: February 27, 2023
In a phase 3 study of patients with severe hemophilia A, a new factor VIII injection given weekly prevented almost all bleeding episodes.
News
- Author:
- Patricia McKnight
Publish date: February 3, 2023
Black patients were more likely to undergo urine drug screening despite being less likely to receive any opioids for pain management.
News
- Author:
- Patricia McKnight
Publish date: January 31, 2023
In a survey of female oncologists, 95% said their career plans were at least somewhat associated with the timing of when to start a family.
News
- Author:
- Patricia McKnight
Publish date: January 20, 2023
Zanubrutinib for treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma has been greenlighted by the FDA.
News
- Author:
- Patricia McKnight
Publish date: January 13, 2023
Treatment decisions should take into account the diagnosis and prognosis of the mother, the gestational age of the fetus, and the potential teratog...
News
- Author:
- Patricia McKnight
Publish date: January 3, 2023
The authors set out to evaluate “the patterns of beliefs about cancer among people who believed in conspiracies, rejected the COVID-19 vaccine, or ...
News
- Author:
- Patricia McKnight
Publish date: December 19, 2022
While trying to avoid COVID-19 infection, patients ultimately diagnosed with multiple myeloma may have delayed interactions with healthcare profess...
News
- Author:
- Patricia McKnight
Publish date: November 7, 2022
“These data suggest some individuals may have unknown metabolic derangements that may underlie the development of both conditions.”
News
- Author:
- Patricia McKnight
Publish date: September 23, 2022
In 2020, selpercatinib received accelerated approval for lung and thyroid RET-positive tumors.
News
- Author:
- Patricia McKnight
Publish date: September 22, 2022
“Historically, there have been no approved treatments for preventing cisplatin-induced hearing loss.”
News
- Author:
- Patricia McKnight
Publish date: September 7, 2022
Ms. Grace suggests that sexual intimacy offers an opportunity for noting physical changes.
